Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs

CD73, ecto-5′-nucleotidase, is the key enzyme catalyzing the conversion of extracellular AMP to adenosine that controls vascular permeability and immunosuppression. Also prostatic acid phosphatase (PAP) possesses ecto-5′-nucleotidase/AMPase activity and is present in leukocytes. However, its role re...

Full description

Saved in:
Bibliographic Details
Main Authors: Gennady G. Yegutkin, Kaisa Auvinen, Marika Karikoski, Pia Rantakari, Heidi Gerke, Kati Elima, Mikael Maksimow, Ileana B. Quintero, Pirkko Vihko, Marko Salmi, Sirpa Jalkanen
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2014/485743
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548803746463744
author Gennady G. Yegutkin
Kaisa Auvinen
Marika Karikoski
Pia Rantakari
Heidi Gerke
Kati Elima
Mikael Maksimow
Ileana B. Quintero
Pirkko Vihko
Marko Salmi
Sirpa Jalkanen
author_facet Gennady G. Yegutkin
Kaisa Auvinen
Marika Karikoski
Pia Rantakari
Heidi Gerke
Kati Elima
Mikael Maksimow
Ileana B. Quintero
Pirkko Vihko
Marko Salmi
Sirpa Jalkanen
author_sort Gennady G. Yegutkin
collection DOAJ
description CD73, ecto-5′-nucleotidase, is the key enzyme catalyzing the conversion of extracellular AMP to adenosine that controls vascular permeability and immunosuppression. Also prostatic acid phosphatase (PAP) possesses ecto-5′-nucleotidase/AMPase activity and is present in leukocytes. However, its role related to immune system is unknown. Therefore, we analyzed enzymatic activities and leukocyte subtypes of CD73 and PAP knockouts and generated CD73/PAP double knockout mice to elucidate the contribution of CD73 and PAP to immunological parameters. Enzymatic assays confirmed the ability of recombinant human PAP to hydrolyze [3H]AMP, although at much lower rate than human CD73. Nevertheless, 5′-nucleotidase/AMPase activity in splenocytes and lymphocytes from PAP−/− mice tended to be lower than in wild-type controls, suggesting potential contribution of PAP, along with CD73, into lymphoid AMP metabolism ex vivo. Single knockouts had decreased number of CD4+/CD25+/FoxP3+ regulatory T cells in thymus and CD73/PAP double knockouts exhibited reduced percentages of CD4+ cells in spleen, regulatory T cells in lymph nodes and thymus, and CD4+ and CD8+ cells in blood. These findings suggest that PAP has a synergistic role together with CD73 in the immune system by contributing to the balance of leukocyte subpopulations and especially to the number of regulatory T cells in lymph nodes and thymus.
format Article
id doaj-art-26c6a64f5c944cc3a3f5370f6e65198f
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-26c6a64f5c944cc3a3f5370f6e65198f2025-02-03T06:12:56ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/485743485743Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid OrgansGennady G. Yegutkin0Kaisa Auvinen1Marika Karikoski2Pia Rantakari3Heidi Gerke4Kati Elima5Mikael Maksimow6Ileana B. Quintero7Pirkko Vihko8Marko Salmi9Sirpa Jalkanen10MediCity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520 Turku, FinlandMediCity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520 Turku, FinlandMediCity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520 Turku, FinlandMediCity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520 Turku, FinlandMediCity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520 Turku, FinlandMediCity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520 Turku, FinlandMediCity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520 Turku, FinlandDepartment of Clinical Chemistry, and Helsinki University Hospital Laboratory, University of Helsinki, 00014 Helsinki, FinlandDepartment of Clinical Chemistry, and Helsinki University Hospital Laboratory, University of Helsinki, 00014 Helsinki, FinlandMediCity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520 Turku, FinlandMediCity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520 Turku, FinlandCD73, ecto-5′-nucleotidase, is the key enzyme catalyzing the conversion of extracellular AMP to adenosine that controls vascular permeability and immunosuppression. Also prostatic acid phosphatase (PAP) possesses ecto-5′-nucleotidase/AMPase activity and is present in leukocytes. However, its role related to immune system is unknown. Therefore, we analyzed enzymatic activities and leukocyte subtypes of CD73 and PAP knockouts and generated CD73/PAP double knockout mice to elucidate the contribution of CD73 and PAP to immunological parameters. Enzymatic assays confirmed the ability of recombinant human PAP to hydrolyze [3H]AMP, although at much lower rate than human CD73. Nevertheless, 5′-nucleotidase/AMPase activity in splenocytes and lymphocytes from PAP−/− mice tended to be lower than in wild-type controls, suggesting potential contribution of PAP, along with CD73, into lymphoid AMP metabolism ex vivo. Single knockouts had decreased number of CD4+/CD25+/FoxP3+ regulatory T cells in thymus and CD73/PAP double knockouts exhibited reduced percentages of CD4+ cells in spleen, regulatory T cells in lymph nodes and thymus, and CD4+ and CD8+ cells in blood. These findings suggest that PAP has a synergistic role together with CD73 in the immune system by contributing to the balance of leukocyte subpopulations and especially to the number of regulatory T cells in lymph nodes and thymus.http://dx.doi.org/10.1155/2014/485743
spellingShingle Gennady G. Yegutkin
Kaisa Auvinen
Marika Karikoski
Pia Rantakari
Heidi Gerke
Kati Elima
Mikael Maksimow
Ileana B. Quintero
Pirkko Vihko
Marko Salmi
Sirpa Jalkanen
Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs
Mediators of Inflammation
title Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs
title_full Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs
title_fullStr Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs
title_full_unstemmed Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs
title_short Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs
title_sort consequences of the lack of cd73 and prostatic acid phosphatase in the lymphoid organs
url http://dx.doi.org/10.1155/2014/485743
work_keys_str_mv AT gennadygyegutkin consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT kaisaauvinen consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT marikakarikoski consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT piarantakari consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT heidigerke consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT katielima consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT mikaelmaksimow consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT ileanabquintero consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT pirkkovihko consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT markosalmi consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans
AT sirpajalkanen consequencesofthelackofcd73andprostaticacidphosphataseinthelymphoidorgans